Authors: BRADER KR MORRIS M LEVENBACK C LEVY L LUCAS KR GERSHENSON DM

Citation: Kr. Brader et al., CHEMOTHERAPY FOR CERVICAL-CARCINOMA - FACTORS DETERMINING RESPONSE AND IMPLICATIONS FOR CLINICAL-TRIAL DESIGN, Journal of clinical oncology, 16(5), 1998, pp. 1879-1884

Authors: MORRIS M LEVENBACK C BURKE TW DEJESUS Y LUCAS KR GERSHENSON DM

Citation: M. Morris et al., AN OUTCOMES MANAGEMENT PROGRAM IN GYNECOLOGIC ONCOLOGY, Obstetrics and gynecology, 89(4), 1997, pp. 485-492

Authors: SEGRETI EM MORRIS M LEVENBACK C LUCAS KR GERSHENSON DM BURKE TW

Citation: Em. Segreti et al., TRANSVERSE COLON URINARY-DIVERSION IN GYNECOLOGIC ONCOLOGY, Gynecologic oncology, 63(1), 1996, pp. 66-70

Authors: SEGRETI EM LEVENBACK C MORRIS M LUCAS KR GERSHENSON DM BURKE TW

Citation: Em. Segreti et al., A COMPARISON OF END AND LOOP COLOSTOMY FOR FECAL DIVERSION IN GYNECOLOGIC PATIENTS WITH COLONIC FISTULAS, Gynecologic oncology, 60(1), 1996, pp. 49-53

Authors: LEVENBACK C BURKE TW MORRIS M MALPICA A LUCAS KR GERSHENSON DM

Citation: C. Levenback et al., POTENTIAL APPLICATIONS OF INTRAOPERATIVE LYMPHATIC MAPPING IN VULVAR CANCER, Gynecologic oncology, 59(2), 1995, pp. 216-220

Authors: CROZIER M MORRIS M LEVENBACK C LUCAS KR ATKINSON EN WHARTON JT

Citation: M. Crozier et al., PELVIC EXENTERATION FOR ADENOCARCINOMA OF THE UTERINE CERVIX, Gynecologic oncology, 58(1), 1995, pp. 74-78